iTeos Therapeutics, Inc. (ITOS) Ownership

$10.15

north_east
$0.02 (0.2%)
Day's range
$10.14
Day's range
$10.17

iTeos Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ECOR1 CAPITAL, LLC 08/14/2025 10.69 M $106.57 M   100.00% 24.54%
BLACKROCK, INC. 08/12/2025 4.57 M $45.61 M   1.45% 10.50%
TANG CAPITAL MANAGEMENT LLC 08/14/2025 3.83 M $38.15 M   42.30% 8.78%
VANGUARD GROUP INC 08/11/2025 1.66 M $16.59 M   -3.61% 3.82%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 832.76 K $8.30 M   -29.50% 1.91%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2025 825.00 K $8.23 M   100.00% 1.89%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 703.47 K $7.02 M   8.22% 1.61%
ORBIMED ADVISORS LLC 08/14/2025 700.00 K $6.98 M   100.00% 1.61%
MARSHALL WACE, LLP 08/13/2025 611.65 K $6.10 M   411.59% 1.40%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 602.10 K $6.00 M   -6.74% 1.38%
JPMORGAN CHASE & CO 08/12/2025 601.36 K $6.00 M   -69.67% 1.38%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/14/2025 596.67 K $5.95 M   100.00% 1.37%
STATE STREET CORP 08/14/2025 594.56 K $5.93 M   2.16% 1.36%
DLD ASSET MANAGEMENT, LP 08/13/2025 576.66 K $5.75 M   100.00% 1.32%
NEWTYN MANAGEMENT, LLC 08/14/2025 567.42 K $5.66 M   100.00% 1.30%
LMR PARTNERS LLP 08/14/2025 550.00 K $5.48 M   100.00% 1.26%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2025 500.00 K $4.99 M   100.00% 1.15%
ALMITAS CAPITAL LLC 08/14/2025 487.20 K $4.86 M   77.09% 1.12%
MILLENNIUM MANAGEMENT LLC 08/14/2025 477.19 K $4.76 M   36.98% 1.10%
MILLENNIUM MANAGEMENT LLC 08/14/2025 342.50 K $3.41 M   100.00% 0.79%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 320.10 K $3.19 M   124.00% 0.73%
STONEPINE CAPITAL MANAGEMENT, LLC 08/13/2025 310.03 K $3.09 M   181.85% 0.71%
BANK OF AMERICA CORP /DE/ 08/14/2025 308.66 K $3.08 M   71.38% 0.71%
RANGELEY CAPITAL, LLC 08/14/2025 302.08 K $3.01 M   100.00% 0.69%
SILVER POINT CAPITAL L.P. 08/14/2025 290.00 K $2.89 M   100.00% 0.67%
NORTHERN TRUST CORP 08/13/2025 258.37 K $2.58 M   3.30% 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 246.09 K $2.45 M   5.36% 0.56%
ALPINE GLOBAL MANAGEMENT, LLC 08/14/2025 225.00 K $2.24 M   100.00% 0.52%
SHAY CAPITAL LLC 08/14/2025 210.52 K $2.10 M   100.00% 0.48%
AMERIPRISE FINANCIAL INC 08/14/2025 207.79 K $2.07 M   4.99% 0.48%
DIADEMA PARTNERS LP 08/14/2025 206.20 K $2.06 M   100.00% 0.47%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2025 204.71 K $2.04 M   100.00% 0.47%
ACADIAN ASSET MANAGEMENT LLC 08/07/2025 186.69 K $1.86 M   -65.22% 0.43%
ROYAL BANK OF CANADA 11/21/2025 185.76 K $1.85 M   10,769.51% 0.43%
PEAPOD LANE CAPITAL LLC 07/31/2025 169.29 K $1.69 M   24.79% 0.39%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 154.96 K $1.54 M   10.59% 0.36%
NUVEEN, LLC 08/12/2025 154.42 K $1.54 M   -49.14% 0.35%
VERITION FUND MANAGEMENT LLC 08/14/2025 150.65 K $1.50 M   241.23% 0.35%
GABELLI & CO INVESTMENT ADVISERS, INC. 08/13/2025 146.45 K $1.46 M   100.00% 0.34%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 144.08 K $1.44 M   296.83% 0.33%
DAFNA CAPITAL MANAGEMENT LLC 08/14/2025 140.85 K $1.40 M   -33.98% 0.32%
JANE STREET GROUP, LLC 08/14/2025 140.30 K $1.40 M   100.00% 0.32%
BARCLAYS PLC 08/14/2025 126.00 K $1.26 M   -2.31% 0.29%
GABELLI FUNDS LLC 08/13/2025 120.59 K $1.20 M   100.00% 0.28%
JANE STREET GROUP, LLC 08/14/2025 116.00 K $1.16 M   100.00% 0.27%
EVERSEPT PARTNERS, LP 08/14/2025 109.32 K $1.09 M   -50.35% 0.25%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 106.40 K $1.06 M   100.00% 0.24%
SIMPLEX TRADING, LLC 08/05/2025 103.21 K $1.03 M   100.00% 0.24%
INVESCO LTD. 08/13/2025 81.04 K $807.92 K   -4.89% 0.19%
AMERICAN CENTURY COMPANIES INC 08/12/2025 78.95 K $787.12 K   5.93% 0.18%

iTeos Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 147 institutional investors and hedge funds held shares of iTeos Therapeutics, Inc.. The most heavily invested institutionals were:

Fisher Asset Management, LLC: 0

OXFORD ASSET MANAGEMENT LLP: 0

Persistent Asset Partners Ltd: 0

SIMPLEX TRADING, LLC: 0

GAMMA Investing LLC: 0

Farther Finance Advisors, LLC: 0

84.47% of iTeos Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 7.50 M shares in the last 24 months. This purchase volume represents approximately $76.15 M in transactions.